Upsher-Smith Laboratories Revenue and Competitors
Estimated Revenue & Valuation
- Upsher-Smith Laboratories's estimated annual revenue is currently $110.3M per year.
- Upsher-Smith Laboratories's estimated revenue per employee is $201,000
Employee Data
- Upsher-Smith Laboratories has 549 Employees.
- Upsher-Smith Laboratories grew their employee count by -3% last year.
Upsher-Smith Laboratories's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Assistant to the President & CEO | Reveal Email/Phone |
2 | Associate VP, Regulatory Affairs | Reveal Email/Phone |
3 | CFO | Reveal Email/Phone |
4 | Medical & Scientific Affairs Associate VP | Reveal Email/Phone |
5 | VP, Human Resources | Reveal Email/Phone |
6 | VP Sales | Reveal Email/Phone |
7 | VP Pharmacy Commercialization | Reveal Email/Phone |
8 | VP, Marketing & Market Access, Specialty, Rare Disease | Reveal Email/Phone |
9 | VP, Partner Relations | Reveal Email/Phone |
10 | Head Commercial Operations | Reveal Email/Phone |
Upsher-Smith Laboratories Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $13.9M | 69 | -13% | N/A | N/A |
#2 | $110.3M | 549 | -3% | N/A | N/A |
#3 | $14.1M | 70 | 1% | N/A | N/A |
#4 | $1051.4M | 5231 | -5% | N/A | N/A |
#5 | $55.9M | 278 | 22% | N/A | N/A |
#6 | $50.3M | 250 | N/A | N/A | N/A |
#7 | $2.2M | 22 | 214% | N/A | N/A |
#8 | $1.4M | 7 | -87% | N/A | N/A |
#9 | $68.1M | 339 | 17% | N/A | N/A |
#10 | $19.5M | 97 | 0% | N/A | N/A |
What Is Upsher-Smith Laboratories?
Upsher-Smith is dedicated to the pursuit of innovative products that enable people to live life to its greatest potential. The evolution of our company is driven by a spirit of collaboration, passion, and the shared goal of making life moments matter for the people who rely on us and our therapies.
keywords:N/A
N/A
Total Funding
549
Number of Employees
$110.3M
Revenue (est)
-3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Upsher-Smith Laboratories News
Novartis, Sanofi, Mylan Pharmaceuticals, Apotex, Upsher-Smith Laboratories, Ferring Pharmaceuticals, Par Pharmaceutical, Torrent, Sun...
... Tolmar Pharmaceuticals, Inc., Novartis AG, Upsher-Smith Laboratories Inc., SottoPelle, Neuva Aesthetics, Ascend Therapeutics.
Global Propafenone Hydrochloride Extended Release Capsule Market 2022 Analysis by Company Share and Growth GSK, Mylan, Upsher-Smith...
MAPLE GROVE, Minn., Aug. 16, 2021 /PRNewswire/ -- Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch of Carbamazepine Extended-Release Tablets, USP in 100 mg, 200 mg and 400 mg strengths. Upsher-Smith's product is AB-rated to the branded product, Tegretol® XR (carbamazepi ...
MAPLE GROVE, Minn., June 25, 2021 /PRNewswire/ -- Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch of Isotretinoin Capsules. Upsher-Smith's product is AB2-rated to the branded product, Absorica® (isotretinoin) capsules. The isotretinoin capsule market had U.S. sales of ...
Other Companies in Maple Grove
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $171.6M | 614 | 5% | N/A |
#2 | $228.2M | 676 | 2% | N/A |
#3 | $201M | 948 | 86% | $319.4M |
#4 | $307.1M | 1567 | 4% | N/A |
#5 | $794.2M | 1607 | 79% | N/A |